NCT07011524View on ClinicalTrials.gov

Study of CM512 Injection in Subjects With Moderate-to-severe Asthma

PHASE2RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 19, 2025

Primary Completion Date

July 21, 2027

Study Completion Date

July 21, 2027

Conditions
Asthma
Interventions
BIOLOGICAL

CM512 injection

subcutaneous injection

DRUG

Placebo

subcutaneous injection

Trial Locations (1)

Unknown

RECRUITING

The First Clinical Hospital of Guangzhou Medical University, Guangzhou

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT07011524 - Study of CM512 Injection in Subjects With Moderate-to-severe Asthma | Biotech Hunter | Biotech Hunter